Comparative efficiency of simple lipopeptide constructs for in vivo induction of virus-specific CTL

Vaccine

Volumn 14, Issue 5, 1996, Pages 375-382

  Deprez, Benoît ^a   Sauzet, Jean Pierre ^b   Boutillon, Christophe ^a   Martinon, Frédéric ^b   Tartar, André ^a   Sergheraert, Christian ^a   Guillet, Jean Gérard ^b   Gomard, Elisabeth ^b   Gras Masse, Hélène ^a  

^a UNIV LILLE   (France)

^b INSTITUT COCHIN   (France)

Author keywords

Cytotoxic T lymphocytes; Lipopeptides; Synthetic vaccines

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LIPOPEPTIDE; SYNTHETIC PEPTIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VACCINATION;

EID: 0030012266     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00220-U     Document Type: Article

References (15)

1. Kovacsovics-Bankowski, M. and Rock, K.L. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 1995, 267, 243-246
2. Deres, K., Schild, H., Wiesmüller, K.H., Jung, G. and Rammensee, H.G. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature 1989, 342, 561-564
3. Deprez, B., Gras-Masse, H., Martinon, F., Gomard, E., Levy, J.P. and Tartar, A. Pimelautide and Trimexautide as built-in adjuvants associated with an HIV-1-derived peptide: synthesis and in vivo induction of antibody and virus-specific cytotoxic T-lymphocytes-mediated response. J. Med. Chem. 1995, 38, 459-465
4. Martinon, F, Gras-Masse, H., Boutillon, C. et al. Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. J. Immunol. 1992, 149, 3416-3422
5. Takahashi, H., Cohen, J., Hosmalin, A. et al. An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. Proc. Natl Acad. Sci. USA 1988, 85, 3105-3109
6. Takahashi, H., Germain, R.N., Moss, B. and Berzofski, J.A. An immunodominant class-I resticted cytotoxic T lymphocyte determinant of human immunodeficiency virus type I induces CD4 class-II restricted help for itself. J. Exp. Med. 1990, 171, 571
7. Ahmad, M.S. and Logani, S.C. Lithium aluminium hydride-aluminium chloride reduction of steroidal cyclic acetals. Aust. J. Chem. 1971, 24, 143-151
8. Merrifield, R.B. Solid phase synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 1963, 85, 2149-2154; Merrifield, R.B. Solid phase synthesis. Science 1986, 232, 341-347
9. Merrifield, R.B. Solid phase synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 1963, 85, 2149-2154; Merrifield, R.B. Solid phase synthesis. Science 1986, 232, 341-347
10. Hudson, D. Methodological implication of simultaneous solid-phase peptide synthesis. 1. Comparison of different coupling procedures. J. Org. Chem. 1988, 53, 617-624. Le-Nguyen, D., Heitz, A. and Castro, B. Renin substrate. Part 2. Rapid solid phase peptide synthesis of the ratine sequence tetradeca-peptide using BOP reagent. J. Chem. Soc. Perkin Trans. 1987, I, 1915-1916
11. Hudson, D. Methodological implication of simultaneous solid-phase peptide synthesis. 1. Comparison of different coupling procedures. J. Org. Chem. 1988, 53, 617-624. Le-Nguyen, D., Heitz, A. and Castro, B. Renin substrate. Part 2. Rapid solid phase peptide synthesis of the ratine sequence tetradeca-peptide using BOP reagent. J. Chem. Soc. Perkin Trans. 1987, I, 1915-1916
12. Fields, G. and Noble, R. Solid phase synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Peptide Protein Res. 1990, 35, 161-214
13. Pouliot, J.F. and Béliveau, R. Modifications post-traductionnelles des proteines par des lipides. Médecine/sciences 1994, 10, 65-73
14. Sauzet, J.P., Deprez, B., Martinon, F., Guillet, J.G., Gras-Masse, H. and Gomard, E. Long-lasting anti-viral cytotoxic T lymphocytes induced in vivo with chimeric-multi-restricted lipopeptides. Vaccine 1995, 12, 1339-1345
15. Bourgault, I., Chirat, F., Tartar, A., Levy, J.P., Guillet, J.G. and Venet, A. Simian immunodeficiency virus as a model for vaccination against HIV. Induction in rhesus macaques of GAG-or NEF-specific cytotoxic lymphocytes by lipopeptides. J. Immunol. 1994, 152, 2530-2537